Kodiak Sciences Advances Retinal Disease Treatment with Zenkuda, Nearing Commercialization
Trendline

Kodiak Sciences Advances Retinal Disease Treatment with Zenkuda, Nearing Commercialization

What's Happening? Kodiak Sciences, a clinical-stage biopharmaceutical company, is nearing a significant milestone with its lead candidate, Zenkuda (tarcocimab tedromer). The drug has successfully completed four Phase 3 studies across various retinal indications, including diabetic retinopathy, retin
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.